+31 (0)24 3666478info@tropIQ.nl
Skip to navigation Skip to content TROPIQ
Navigation
  • HOME
  • ABOUT US
  • OUR TECHNOLOGY
  • PATHOGENS AND VECTORS
  • NEWS
  • PUBLICATIONS
  • CONTACT
  • HOME
  • ABOUT US
  • OUR TECHNOLOGY
  • PATHOGENS AND VECTORS
  • NEWS
  • PUBLICATIONS
  • CONTACT

Author: Monique

basic post new style

By Monique08/10/201808/10/2018 Categories: example post

Add post text favicon

TropIQ receives price for Dutch innovative startup

By Monique06/12/201614/04/2017 Categories: News

TropIQ receives the Unilever Sustainable Innovation Prize for the Dutch innovative startup best contributing to the Sustainable Development Goals as put forward by the United Nations.

Diversity-oriented synthesis yields novel multistage antimalarial inhibitors.

By Monique20/10/201620/04/2017 Categories: Publications

Kato N, et. al., Nature. 2016 Oct 20 ABSTRACT Antimalarial drugs have thus far been chiefly derived from two sources-natural products and synthetic drug-like compounds. Here we investigate…

TropIQ staff co-authors publication on novel antimalarial compound

By Monique04/10/201619/04/2017 Categories: News

October 4, 2016. TropIQ staff co-author the study ‘Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose–Efficacy Modeling’ published in PloS Medicine today.

Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.

By Monique04/10/201619/04/2017 Categories: Publications

Artemisinin resistance observed in Southeast Asia threatens the continued use of artemisinin-based combination therapy in endemic countries.

TropIQ is awarded with a ‘Pearl of the region’

By Monique15/09/201606/03/2017 Categories: News

TropIQ is awarded with a ‘Pearl of the region’ award by The Economic Board. Waarom roept The Economic Board ‘parels van de regio’ in het leven? De Board…

TropIQ staff co-authors paper in Nature

By Monique07/09/201606/03/2017 Categories: News

Nature publishes the paper ‘Diversity-oriented synthesis yields novel multistage antimalarial inhibitors’ that is co-authored by TropIQ staff. Antimalarial drugs have thus far beenchiefly derived from two sources—natural products…

TROPIQ Health Sciences

Transistorweg 5-C02
6534 AT Nijmegen
The Netherlands

T +31 (0)24 3666478
Send an email

© TropIQ 2017 -

On this website:

  • HOME
  • ABOUT US
  • OUR TECHNOLOGY
  • PATHOGENS AND VECTORS
  • NEWS
  • PUBLICATIONS
  • CONTACT
Webdesign GRAPHX 66